| ¿µ¹® | nuclear medicine | ÇÑ±Û | ÇÙÀÇÇÐ |
|---|---|---|---|
| ¼³¸í | ¹æ»ç¼ºÀ» ¶ì´Â ÇÙ¹°ÁúÀ» ÀÌ¿ëÇÏ¿© ÀÇÇп¡ ÀÀ¿ëÇÏ´Â Çй®. ´ë°³ ÀÎü¿¡ Å« ÇØ°¡ ¾ø´Â ¹æ»ç¼±¹°ÁúÀ» »ç¿ëÇϸç, ¹Ý°¨±â°¡ ª¾Æ »ç¿ëÈÄ¿¡µµ Å« ÇØ°¡ ¾ø´Ù. ÀÌ·± ÇÙÀÇÇÐÀû ¹°ÁúÀ» ÀÌ¿ëÇÑ ÇÙÀÇÇÐÀû Áø´ÜÀÇ °¡Àå Å« ÀåÁ¡Àº »ýü³»¿¡¼ ÀϾ´Â ±× ±â°üÀÇ ½ÇÁ¦ÀûÀÎ ±â´ÉÀ» ¾Ë¾Æº¼ ¼ö ÀÖ´Ù´Â µ¥ ÀÖ´Ù. ÈçÈ÷ Á¢ÇÏ´Â X-¼±À» ÀÌ¿ëÇÑ Áø´Ü¹æ¹ýÀº ´ÜÁö ±× ¼ø°£¸¸ÀÇ ¿µ»óÀ» Á¢ÇÏ¿© ½ÇÁ¦·Î º¸ÀÌ´Â ºÎÀ§°¡ ¾ó¸¶³ª ±â´ÉÀ» ¼öÇàÇÏ´ÂÁö ¾Ë ¼ö ¾ø´Â ´ÜÁ¡ÀÌ ÀÖÀ¸³ª, ÇÙÀÇÇп¡¼´Â ½ÇÁ¦ÀûÀÎ ±â´ÉÀÇ Á¤µµ¿¡ µû¶ó ¿µ»óÀÌ ³ª¿À°Ô µÇ¹Ç·Î ±â´ÉÆÇº°¿¡ ¾ÆÁÖ À¯¸®ÇÏ´Ù. ÇÏÁö¸¸, Á¤È®ÇÑ ÆÇº°·ÂÀÌ ÀÖ´Â ¿µ»óÀ» ¾ò±â¿¡´Â ºÎÁ·ÇÏ´Ù. ¶ÇÇÑ ÇÙÀÇÇÐÀº Áø´Ü¿ÜÀÇ Ä¡·á¿¡µµ »ç¿ëµÇ´Âµ¥, ¿¹¸¦ µé¾î °©»ó»ùÁ¾¾çÀÇ °æ¿ì ¿©·¯ °÷¿¡ ÀÌ¹Ì ÀüÀ̰¡ µÇ¾î ÀÖÀ» °æ¿ì ¹æ»ç¼±ÇÙÁ¾À» ÀÌ¿ëÇÏ¿© ´Ù¸¥ °÷¿¡ Å« ºÎÀÛ¿ë¾øÀÌ Ä¡·á°¡ °¡´ÉÇÏ´Ù. |
||
| ¿µ¹® | nuclear magnetic resonance(NMR) | ÇÑ±Û | ÇÙÀÚ±â°ø¸í |
|---|---|---|---|
| ¼³¸í | ´Ù¸¥ ¸»·Î MRI=Magnetic Resonance Imaging ÀÚ±â°ø¸í¿µ»óÀ̶ó°íµµ ÇÑ´Ù. ÀÎüÀÇ Àå±â³ª, º´ÀûÀÎ ¸ð¾ç, Á¾¾çÀÇ À§Ä¡, ¸²ÇÁÀýÀÇ ºñ´ë µî¿¡ ´ëÇÑ Áø´ÜÀ» ³»¸®±â À§ÇØ ½ÃÇàÇÏ´Â ¹æ»ç¼±ÇÐÀûÀÎ °Ë»ç¹æ¹ýÀÌ´Ù. ÇöÀç ¸¹ÀÌ ¾²À̰í ÀÖ´Â ÄÄÇ»ÅÍ´ÜÃþÃÔ¿µ(CT=computerized tomography)°ú´Â ´Ù¸¥ ¹æ¹ýÀ¸·Î ½ÃÇàÇϸç, ±× ÇØ»óµµ°¡ ÄÄÇ»ÅÍ´ÜÃþÃÔ¿µº¸´Ù´Â ¶Ù¾î³ª ºñ·Ï °í°¡À̱ä ÇÏÁö¸¸, ¸¹ÀÌ ¾²À̰í ÀÖ´Ù. ¶ÇÇÑ ÀÎü¿¡ ¹«ÇØÇϰí, ¿©·¯ °¡Áö ¸é(plane)¿¡¼ »ç¶÷À» ´ÜÃþ½ÃÄÑ º¼ ¼ö ÀÖ´Ù. ´ÜÁ¡Àº ½ÉÀå¹Úµ¿±â¸¦ ¼³Ä¡ÇÑ »ç¶÷À̳ª, ÁÖÀ§¿¡ ÀÚÀåÀ» ¶ì´Â ¹°Ã¼¸¦ ¸ö¿¡ Áö´Ï°í ÀÖ´Â ÁßȯÀÚ µî¿¡¼´Â ÀÌ¿ëÇÒ ¼ö ¾ø°í, º¹ºÎÀå±â¿¡ ´ëÇÑ Áø´Ü¿¡´Â ÄÄÇ»ÅÍ´ÜÃþÃÔ¿µº¸´Ù ¶³¾îÁö´Â °ÍÀ¸·Î µÇ¾î ÀÖ´Ù. |
||
| NM | near-miss; neomycin; neuromedin; neuromuscular; neutrophil migration; nictitating membrane; nitrogen... |
|---|---|
| PIF | 1) Proliferation Inhibitory Factor 2) Prolactin release Inhibiting Factor... |
| ALEP | atypical lymphoepithelioid cell proliferation |
| DMP | diffuse mesangial proliferation; dimercaprol; dimethylphthalate |
| EMP | electric membrane property; electromagnetic pulse; Embden-Meyerhof pathway; external membrane potent... |
| PCNA | Proliferation Cell Nuclear Antigen |
|---|---|
| LPT | Lymphocyte Proliferation Test |
| LP | Lymphocyte proliferation |
| MPP | Massive periretinal proliferation |
| PI | Proliferation Index |
| gingival proliferation | Non-inflammatory enlargement of the gingivae produced by factors other than local irritation. It is characteristically due to an increase in the number of cells. (12 Dec 1998) |
|---|---|
| regulatory cell proliferation kinase | <enzyme> Involved in mitosis regulation; has characteristics of serine/threonine and tyrosine kinases; isolated from saccharomyces cerevisiae; genbank l08909 Registry number: EC 2.7.1.- Synonym: rpk1 protein, rpk1 gene product (26 Jun 1999) |
| cell proliferation | <cell biology> Increase in cell number by division. (26 Mar 1998) |
| proliferation | <cell biology> The reproduction or multiplication of similar forms, especially of cells and morbid cysts. Origin: L. Proles = offspring, ferre = to bear (18 Nov 1997) |
| proliferation cyst | A mother cyst containing daughter cyst's; a cyst with tumourous formation at one portion of the sac. (05 Mar 2000) |
| proliferation therapy | Rehabilitation of an incompetent structure (ligament or tendon) by the induced proliferation of new cells; accomplished by injecting an irritating substance into the loose ligament or tendon, the resulting scar formation and contracture serving to tighten up the ligament or tendon as scar tissue proliferates. (05 Mar 2000) |
| diffuse mesangial proliferation | <nephrology, pathology> Inflammation of the kidney glomerulus (blood filtering portion of the kidney) due to the abnormal deposition of IgM antibody in the mesangium layer of the glomerular capillary. A form of glomerulonephritis that appears to be caused by an abnormal immune response. This disorder generally manifests as nephrotic syndrome. Symptoms include swelling, dark urine, weight gain, hypertension, anorexia and bloody urine. Acronym: MPGN (05 Jan 1998) |
| receptors, cytoplasmic and nuclear | Proteins in the cytoplasm or nucleus that specifically bind signalling molecules and trigger changes which influence the behaviour of cells. The major groups are the steroid hormone receptors, which usually are found in the cytoplasm, and the thyroid hormone receptors, which usually are found in the nucleus. Receptors, unlike enzymes, generally do not catalyze chemical changes in their ligands. (12 Dec 1998) |
| Remak's nuclear division | <cell biology> An unusual form of nuclear division, in which the nucleus simply constricts, rather like a cell without chromosome condensation or spindle formation. Partitioning of daughter chromosomes is haphazard. Observed in some Protozoa. (18 Nov 1997) |
| Pelger-Huet nuclear anomaly | Congenital inhibition of lobulation in the nuclei of neutrophilic leukocytes; most cells present band or bilobulate appearance, and only an occasional cell is trilobed; it is not associated with disease, but may be confused with leukocyte "shift to left"; autosomal dominant inheritance. (05 Mar 2000) |
| ribonucleoproteins, small nuclear | Highly conserved nuclear RNA-protein complexes that function in RNA processing in the nucleus, including pre-mRNA splicing and pre-mRNA 3'-end processing in the nucleoplasm. The u3 snrnp is localised in the nucleolus, where it aligns into base pairs with the 28s rrna precursor in a still unidentified region and functions in pre-rrna processing. The u7 snrnp aligns into base pairs with a conserved sequence in the 3'-end of histone pre-mRNA and is an essential cofactor for the cleavage that creates the mature nonadenylated 3'-end. (12 Dec 1998) |
| RNA, heterogeneous nuclear | Nuclear nonribosomal RNA larger than about 1000 nucleotides, the mass of which is rapidly synthesised and degraded within the cell nucleus. Some heterogeneous nuclear RNA may be a precursor to mRNA. However, the great bulk of total hnrna hybridises with nuclear DNA rather than with mRNA. (12 Dec 1998) |
| RNA, nuclear | RNA molecules found in the nucleus either associated with chromosomes or in the nucleoplasm. (12 Dec 1998) |
| RNA, small nuclear | Short chains of RNA found in the nucleus. Their function is to remove the introns (nontranslated intervening sequences) from mRNA precursors, thereby bringing the two exons (coding segments) together into correct juxtaposition for enzymatic splicing at the correct point. The resulting mRNA is now ready to leave the nucleus. (12 Dec 1998) |
| rod nuclear cell | <pathology> Immature neutrophils released from the bone marrow reserve in response to acute demand. (18 Nov 1997) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|